Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
2.920
-0.120 (-3.95%)
At close: Nov 20, 2024, 4:00 PM
2.870
-0.050 (-1.71%)
Pre-market: Nov 21, 2024, 5:50 AM EST
SONN Employees
Sonnet BioTherapeutics Holdings had 12 employees as of September 30, 2023. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$4,657
Profits / Employee
-$665,448
Market Cap
1.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2023 | 12 | 0 | - |
| Sep 30, 2022 | 12 | 3 | 33.33% |
| Sep 30, 2021 | 9 | 0 | - |
| Sep 30, 2020 | 9 | -21 | -70.00% |
| Sep 30, 2019 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| iCoreConnect | 70 |
| Phio Pharmaceuticals | 9 |
| Shuttle Pharmaceuticals Holdings | 8 |
| Dermata Therapeutics | 8 |
| Aclarion | 6 |
| Qualigen Therapeutics | 4 |
| GRI Bio | 4 |
| IMAC Holdings | 4 |
SONN News
- 8 days ago - Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment - GlobeNewsWire
- 14 days ago - Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 14 days ago - Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates - GlobeNewsWire
- 4 weeks ago - Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq - GlobeNewsWire
- 6 weeks ago - Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India - GlobeNewsWire
- 6 weeks ago - Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs - GlobeNewsWire
- 7 weeks ago - Sonnet BioTherapeutics Announces Launch of CEO Corner Platform - GlobeNewsWire
- 2 months ago - Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split - GlobeNewsWire